Abstract
PURPOSE: The purpose of this study was to determine whether a complete pathologic response after neoadjuvant therapy in rectal cancer patients improves disease control and survival. METHODS: The study reviewed Stage II and III rectal cancer patients treated with preoperative chemoradiation and resected for cure. Complete pathologic response was defined as no cancer in the resected specimen. The main outcome measures were cancer-specific and disease-free survival in patients achieving a complete pathologic response and a noncomplete pathologic response. Kaplan-Meier curves were evaluated using log-rank analysis. RESULTS: Eighty-nine rectal cancer patients received neoadjuvant chemoradiation followed by radical resection for cure. Twenty-one patients (24 percent) achieved a complete pathologic response. Median follow-up for the complete pathologic response group was 23.5 months and 31 months for the noncomplete pathologic response group. There were more Stage III patients in the noncomplete pathologic response group than the complete pathologic response group (P = 0.005). Complete pathologic response patients were less likely to receive postoperative adjuvant chemotherapy than noncomplete pathologic response patients (P = 0.004). Cancer-specific and disease-free survival were not statistically different between the two groups. However, a trend was noted toward improved survival and decreased recurrence in association with a complete pathologic response. CONCLUSION: Stage III patients were less likely to be in the complete pathologic response group than Stage II patients. Complete pathologic response patients were less likely to receive postoperative adjuvant chemotherapy than noncomplete pathologic response patients. Complete pathologic response after neoadjuvant chemoradiation for rectal cancer patients demonstrated a trend toward improved survival and decreased recurrence compared with noncomplete pathologic response patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
TA Rich JM Skibber JA Ajani et al. (1995) ArticleTitlePreoperative infusional chemoradiation therapy for stage T3 rectal cancer Int J Radiat Oncol Biol Phys 32 1025–1029
A Grann BS Feng D Wong et al. (2001) ArticleTitlePreoperative combined modality therapy for clinically resectable UT3 rectal adenocarcinoma Int J Radiat Oncol Biol Phys 49 987–995
TE Read OA Ogunbiyi JW Fleshman et al. (2001) ArticleTitleNeoadjuvant external beam radiation and proctectomy for adenocarcinoma of the rectum Dis Colon Rectum 44 1778–1790
NR Ahmad DA Nagle A Topham (1997) ArticleTitlePathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer [abstract] Int J Radiat Oncol Biol Phys 39 284–1790
J Garcia-Aguilar E Hernandez de Anda P Sivivongs SH Lee RD Madoff DA Rothenberger (2003) ArticleTitleA pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 298–304
N Janjan V Khoo J Abbruzzese et al. (1999) ArticleTitleTumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 44 1027–1038
C Berger A De Muret P Garaud et al. (1997) ArticleTitlePreoperative radiotherapy for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications Int J Radiat Oncol Biol Phys 37 619–627
JN Vauthey R Marsh RA Zlotecki et al. (1999) ArticleTitleRecent advances in the treatment and outcome of locally advanced rectal cancer Ann Surg 229 745–754
MW Onaitis RB Noone M Hartwig et al. (2001) ArticleTitleNeoadjuvant chemoradiation for rectal cancer Ann Surg 233 778–785
S Hiotis S Weber AM Cohen et al. (2002) ArticleTitleAssessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer J Am Coll Surg 194 131–136
BD Minsky AM Cohen N Kemeny et al. (1992) ArticleTitleEnhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy J Clin Oncol 10 79–84
RJ Heald RD Ryall (1986) ArticleTitleRecurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1479–1482
WB Merchant JG Guillem PB Paty et al. (1999) ArticleTitleT3N0 rectal cancer J Gastrointest Surg 3 642–647
E Kapiteijn CA Marijnen ID Nagtegaal et al. (2001) ArticleTitlePreoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Dutch Colorectal Cancer Group N Engl J Med 345 638–646
RJ Myerson A Singh EH Birnbaum et al. (2001) ArticleTitlePretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer Int J Radiat Oncol Biol Phys 50 665–674
InstitutionalAuthorNameAnonymous (1990) ArticleTitleNIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1444–1450
InstitutionalAuthorNameGastrointestinal Tumor Study Group (1985) ArticleTitleProlongation of the disease-free survival in surgically treated rectal carcinoma. N Engl J Med 12 1565–1573
InstitutionalAuthorNameStockholm Rectal Cancer Study Group (1990) ArticleTitlePreoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66 49–55
InstitutionalAuthorNameMedical Research Council Rectal Cancer Working Party (1996) ArticleTitleRandomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 348 1605–1610
InstitutionalAuthorNameSwedish Rectal Cancer Trial (1997) ArticleTitleImproved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 980–987
JW Fleshman RJ Myerson (1997) ArticleTitleAdjuvant radiation therapy for adenocarcinoma of the rectum Surg Clin North Am 77 15–25
PJ Marsh RD James PF Schofield (1994) ArticleTitleAdjuvant preoperative radiotherapy for locally advanced rectal carcinoma Dis Colon Rectum 37 1205–1214
A Gerard M Buyse B Nordlinger et al. (1988) ArticleTitlePreoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European organization for research and treatment of cancer (EORTC) Ann Surg 208 606–614
B Fisher N Wolmark H Rockette et al. (1988) ArticleTitlePostoperative adjuvant chemotherapy or radiation therapy for rectal cancer J Natl Cancer Inst 80 21–29
MC Posner WE Gooding JI Lew et al. (2001) ArticleTitleComplete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer Surgery 130 620–628
MC Kaminsky-Forrett T Conroy E Luporsi et al. (1998) ArticleTitlePrognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer Int J Radiat Oncol Biol Phys 42 935–941
DR Adams GJ Blatchford KM Lin CA Ternent AG Thorson MA Christensen (1999) ArticleTitleUse of preoperative ultrasound staging for treatment of rectal cancer Dis Colon Rectum 42 159–166
Author information
Authors and Affiliations
About this article
Cite this article
Brown, C.L., Ternent, C.A., Thorson, A.G. et al. Response to Preoperative Chemoradiation in Stage II and III Rectal Cancer. Dis Colon Rectum 46, 1189–1193 (2003). https://doi.org/10.1007/s10350-004-6714-y
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6714-y